メチルジャスモナートは,Mycobacterium tuberculosis感染中にオートファギーを活性化することによって宿主の防御を促進します
Asmita Sapkota1, Young Jae Kim2, Ji Woong Yu2
1Department of Microbiology, Chungnam National University College of Medicine, Daejeon 35015, Republic of Korea.
まとめ
メチルジャスモナート (MeJA) は,オートファギーを活性化し,炎症を軽減することにより,Mycobacterium tuberculosisに対する宿主の防御を強化し,結核に対する潜在的な植物由来療法を提供しています.
科学分野:
- 植物生物学と免疫学について
- 微生物学と感染症
- 薬剤の発見と開発について
背景:
- ジャスモネートは,抗菌作用が知られている植物ホルモンです.
- 哺乳類の抗微生物反応,特にMycobacterium tuberculosis (Mtb) に対するジャスモネートの役割はほとんど不明である.
- 多剤耐性菌株を含む結核は,新しい治療戦略を必要とします.
研究 の 目的:
- メチルジャスモナート (MeJA) がMtb.に対する宿主指向療法としての可能性を調査する.
- 哺乳類の細胞および体内におけるMeJAの抗菌効果を評価する.
主な方法:
- MeJAの直接的な抗菌細菌作用を評価する.
- Mtb感染時のマクロファージおよび肺組織反応に対するMeJAの影響を評価.
- 炎症誘発性サイトカインとケモカイン発現に対するMeJAの影響を分析.
- AKT-MTOR経路,オートファギー,およびリソソーム遺伝子発現に対するMeJAの影響を調査する.
- 転写因子EB (TFEB) の核転位に対するMeJAの影響を検証する.
主要な成果:
- MeJAは直接的な抗ミコバクテリア活性を示さなかったが,多剤耐性菌株を含むMtbに対する宿主抗菌反応を誘発した.
- MeJAは,マクロファージと肺組織における炎症誘発性サイトカインとキモカインの発現を著しく低下させた.
- MeJA治療は,AKT-MTOR軸を阻害し,TFEB活性化によるオートファジーとリソソーム遺伝子発現を促進しました.
- MeJAは強烈にオートファギーを活性化し,ファゴソームの成熟と宿主の防御を強化しました.
結論:
- メチルジャスモナート (MeJA) は,菌根菌感染症に対する植物由来治療剤として有望であることが示されています.
- MeJAは,炎症を調節し,オートファギーを活性化することによって宿主の防衛機構を強化します.
- これらの発見は,結核と闘うために宿主反応を標的とした新しい戦略の開発を支援しています.
関連する概念動画
01:31Defense Against Bacterial Pathogens
3.1K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.1K
01:27Autophagy
6.0K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.0K
01:18Autophagic Cell Death
4.7K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.7K
01:28Pulmonary Tuberculosis II
1.7K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.7K
01:20The JAK-STAT Signaling Pathway
13.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.3K
01:40Cell-mediated Immune Responses
84.7K
Overview
84.7K